The maths behind combination therapy

Nature Reviews Clinical Oncology

Volumn 10, Issue 9, 2013, Pages 488-

  Kirk, Rebecca ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

VEMURAFENIB;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CLINICAL PROTOCOL; DRUG TREATMENT FAILURE; HUMAN; INTERMETHOD COMPARISON; MELANOMA; METASTATIC COLORECTAL CANCER; MOLECULAR EVOLUTION; NOTE; PANCREAS CANCER; POINT MUTATION; PRIORITY JOURNAL; STOCHASTIC MODEL; TUMOR VOLUME;

EID: 84883456568     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2013.131     Document Type: Note

References (2)

1. Burns, M. B. et al. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. doi:10.1038/ng.2701 | Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. doi:10.1038/ng.2702
2. Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. doi:10.1038/ng.2702